Jasmina I Ivanova

Summary

Affiliation: Analysis Group
Country: USA

Publications

  1. doi request reprint Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US
    J I Ivanova
    Analysis Group, Inc, New York, NY, USA
    J Med Econ 15:601-9. 2012
  2. doi request reprint Duloxetine use in chronic low back pain: treatment patterns and costs
    Jasmina I Ivanova
    Analysis Group, Inc, New York, NY 10020, USA
    Pharmacoeconomics 30:595-609. 2012
  3. doi request reprint Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma
    Jasmina I Ivanova
    Analysis Group, Inc, New York, NY 10020, USA
    J Allergy Clin Immunol 129:1229-35. 2012
  4. ncbi request reprint Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insurance
    Jasmina I Ivanova
    Analysis Group, Inc, New York, USA
    Am J Manag Care 17:e314-23. 2011
  5. doi request reprint Physicians' decisions to prescribe antidepressant therapy in older patients with depression in a US managed care plan
    Jasmina I Ivanova
    Analysis Group, Inc, New York, New York 10020, USA
    Drugs Aging 28:51-62. 2011
  6. doi request reprint Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder
    Jasmina I Ivanova
    Analysis Group, Inc, New York, NY 10020, USA
    Curr Med Res Opin 26:2475-84. 2010
  7. ncbi request reprint Real-world practice patterns, health-care utilization, and costs in patients with low back pain: the long road to guideline-concordant care
    Jasmina I Ivanova
    Analysis Group, Inc, New York, NY 10020, USA
    Spine J 11:622-32. 2011
  8. ncbi request reprint Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States
    Jasmina I Ivanova
    Analysis Group, Inc, New York City, New York, USA
    Epilepsia 51:838-44. 2010
  9. doi request reprint The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US
    Jasmina I Ivanova
    Analysis Group, Inc, New York, New York, USA
    Pharmacoeconomics 27:681-91. 2009
  10. ncbi request reprint Adherence to inhaled corticosteroid use and local adverse events in persistent asthma
    Jasmina I Ivanova
    Analysis Group Inc, New York, NY 10020, USA
    Am J Manag Care 14:801-9. 2008

Detail Information

Publications22

  1. doi request reprint Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US
    J I Ivanova
    Analysis Group, Inc, New York, NY, USA
    J Med Econ 15:601-9. 2012
    ..To compare rates of severe relapse and total direct and indirect costs over a 2-year period between US-based employees with multiple sclerosis (MS) who were adherent and non-adherent to disease-modifying drugs (DMDs)...
  2. doi request reprint Duloxetine use in chronic low back pain: treatment patterns and costs
    Jasmina I Ivanova
    Analysis Group, Inc, New York, NY 10020, USA
    Pharmacoeconomics 30:595-609. 2012
    ..Little is known about the real-world treatment patterns and costs of patients with chronic low back pain (CLBP) who are treated with duloxetine compared with those receiving other non-surgical treatments...
  3. doi request reprint Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma
    Jasmina I Ivanova
    Analysis Group, Inc, New York, NY 10020, USA
    J Allergy Clin Immunol 129:1229-35. 2012
    ..Health care costs increase in patients with more severe asthma, but the effect of asthma exacerbations on costs among patients with more severe asthma has not been quantified...
  4. ncbi request reprint Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insurance
    Jasmina I Ivanova
    Analysis Group, Inc, New York, USA
    Am J Manag Care 17:e314-23. 2011
    ..To compare healthcare costs and resource utilization among patients with post-traumatic stress disorder (PTSD) vs control subjects with major depressive disorder (MDD) in populations covered by Medicaid or private insurance...
  5. doi request reprint Physicians' decisions to prescribe antidepressant therapy in older patients with depression in a US managed care plan
    Jasmina I Ivanova
    Analysis Group, Inc, New York, New York 10020, USA
    Drugs Aging 28:51-62. 2011
    ..Published studies indicate that depression in older adults is severely under-recognized and under-treated...
  6. doi request reprint Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder
    Jasmina I Ivanova
    Analysis Group, Inc, New York, NY 10020, USA
    Curr Med Res Opin 26:2475-84. 2010
    ..The objective of this study was to assess direct healthcare costs and indirect (disability and medical-related absenteeism) costs associated with TRD compared with non-treatment-resistant major depressive disorder (MDD)...
  7. ncbi request reprint Real-world practice patterns, health-care utilization, and costs in patients with low back pain: the long road to guideline-concordant care
    Jasmina I Ivanova
    Analysis Group, Inc, New York, NY 10020, USA
    Spine J 11:622-32. 2011
    ..Treatment guidelines suggest that most acute low back pain (LBP) episodes substantially improve within a few weeks and that immediate use of imaging and aggressive therapies should be avoided...
  8. ncbi request reprint Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States
    Jasmina I Ivanova
    Analysis Group, Inc, New York City, New York, USA
    Epilepsia 51:838-44. 2010
    ..Compare annual direct and indirect costs between privately insured U.S. patients with epileptic partial onset seizures (POS) and matched controls...
  9. doi request reprint The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US
    Jasmina I Ivanova
    Analysis Group, Inc, New York, New York, USA
    Pharmacoeconomics 27:681-91. 2009
    ..0001). MS is a chronic and debilitating disease that poses a substantial employer burden in terms of medically related absenteeism and disability costs. Indirect costs of employees with MS were >4 times those of employee controls...
  10. ncbi request reprint Adherence to inhaled corticosteroid use and local adverse events in persistent asthma
    Jasmina I Ivanova
    Analysis Group Inc, New York, NY 10020, USA
    Am J Manag Care 14:801-9. 2008
    ....
  11. doi request reprint Economic burden of epilepsy among the privately insured in the US
    Jasmina I Ivanova
    Analysis Group, Inc, New York, NY 10020, USA
    Pharmacoeconomics 28:675-85. 2010
    ..0001), with a difference of $US8257. Conclusions: Epilepsy was associated with significant economic burden. The excess direct costs in patients with epilepsy are underestimated when only epilepsy-related costs are considered...
  12. doi request reprint Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%
    Noam Y Kirson
    Analysis Group, Inc, Boston, MA 02199, USA
    J Med Econ 13:472-81. 2010
    ..Repeat comparison for the subset of patients treated in long-term care (LTC) settings...
  13. ncbi request reprint Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs
    Howard G Birnbaum
    Analysis Group, Inc, Boston, MA, USA
    Curr Med Res Opin 25:869-77. 2009
    ..The study objective is to compare the annual total medical and indirect costs of newly treated and untreated employees with multiple sclerosis (MS)...
  14. doi request reprint Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population
    Noam Y Kirson
    Analysis Group, Inc, Boston, MA, USA
    Appl Health Econ Health Policy 9:377-87. 2011
    ..Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and potentially fatal disease. Little is known about the economic burden associated with CTEPH patients in the US...
  15. doi request reprint The prevalence and economic impact of prescription opioid-related side effects among patients with chronic noncancer pain
    Jasmina I Ivanova
    Manager, Analysis Group, Inc, New York, New York
    J Opioid Manag 9:239-54. 2013
    ....
  16. doi request reprint Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population
    Noam Y Kirson
    Analysis Group, Inc, Boston, MA, USA
    Appl Health Econ Health Policy 9:293-303. 2011
    ..Pulmonary arterial hypertension (PAH) is a rare but fatal disease. Little is known about the economic burden associated with PAH patients in the US...
  17. doi request reprint Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin
    Noam Y Kirson
    Analysis Group, Inc, Boston, MA 02199, USA
    J Med Econ 13:482-91. 2010
    ..To compare healthcare resource utilization and costs of postherpetic neuralgia (PHN) patients initiating lidocaine patch 5% (lidocaine patch) or oral gabapentin/pregabalin...
  18. pmc Evaluating the utility of existing patient-reported outcome scales in novel patient populations with pancreatic cancer, lung cancer, and myeloproliferative neoplasms using medicare current beneficiary survey data
    Jasmina I Ivanova
    Analysis Group, Inc, New York, NY, USA
    Patient 6:189-200. 2013
    ....
  19. ncbi request reprint Duloxetine use in employees with low back pain: treatment patterns and direct and indirect costs
    Jasmina I Ivanova
    Analysis Group, Inc, New York, New York, USA
    Pain Med 15:1015-26. 2014
    ..The study aims to examine real-world effects of duloxetine treatment for low back pain (LBP)...
  20. ncbi request reprint Real-world role of tricyclic antidepressants in the treatment of fibromyalgia
    Catherine Reed
    Lilly Research Centre, Windlesham, Surrey, UK
    Pain Pract 12:533-40. 2012
    ..To examine the real-world role of tricyclic antidepressants (TCAs) in fibromyalgia (FM) treatment...
  21. ncbi request reprint Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies
    Eric Q Wu
    Analysis Group, Inc, Boston, MA 02199, USA
    J Manag Care Pharm 13:561-9. 2007
    ....
  22. ncbi request reprint Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States
    Noam Y Kirson
    Analysis Group, Inc, Boston, MA, USA
    Curr Med Res Opin 27:1763-8. 2011
    ..The prevalence of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in the US is largely unknown. Prior research has estimated PAH prevalence in Europe at ∼15-52 per million...